GlassScriptPhysician profile
Kenneth Madsen
NPI 1164412862
$10,929.63
in general payments reported to CMS, 2019-2025
37 companies · $2,023 in 2025
The $2,023 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,512 · 2020: $230 · 2021: $560 · 2022: $1,162 · 2023: $1,242 · 2024: $4,201 · 2025: $2,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,999 · Travel and Lodging: $2,467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,998.86 |
| Travel and Lodging | $2,466.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,502.27 | 2020-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Silk Road Medical, INC. | $1,621.86 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Medtronic, INC. | $1,466.06 | 2022-2025 | Ellipsys Vascular Access System, Venaseal, Hawkone |
| Boston Scientific Corporation | $1,070.64 | 2022-2025 | Enroute Transcarotid Neuroprotection System, Jetstream Sc |
| Globus Medical, INC. | $793.75 | 2019 | |
| Shockwave Medical, INC | $531.83 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $416.42 | 2019 | |
| Inari Medical, INC. | $360.18 | 2021 | |
| Stryker Corporation | $346.69 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Clottriever Bold Catheter |
| Paratek Pharmaceuticals, INC. | $243.17 | 2022 | |
| Cook Medical LLC | $212.58 | 2021-2025 | Zenith, Lunderquist, Cook |
| Penumbra, INC. | $193.11 | 2025 | Penumbra System |
| Janssen Pharmaceuticals, INC | $181.34 | 2019-2021 | |
| Cagent Vascular INC | $133.52 | 2024 | Serrantor |
| Organogenesis INC. | $110.62 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $94.65 | 2025 | Esprit |
| Endologix LLC | $66.22 | 2021 | |
| Tactile Systems Technology INC | $64.31 | 2019-2020 | |
| Cardiovascular Systems INC. | $61.00 | 2019-2021 | |
| Angiodynamics, INC. | $59.45 | 2020-2021 | |
| Smith+Nephew, INC. | $57.44 | 2022-2023 | Grafix |
| Siemens Medical Solutions USA, INC. | $54.51 | 2023 | Acuson Juniper Diagnostic Ultrasound System |
| Getinge USA Sales, LLC | $45.02 | 2019-2021 | |
| Kci USA, INC. | $30.52 | 2019 | |
| Bard Peripheral Vascular, INC. | $30.14 | 2022 | |
| Reflow Medical INC | $25.70 | 2025 | |
| Integra Lifesciences Corporation | $21.05 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Atricure, INC. | $20.52 | 2019 | |
| Baxter Healthcare | $18.88 | 2024 | Perclot |
| Mozarc Medical US LLC | $17.58 | 2023 | Palindrome |
| Philips North America LLC | $14.08 | 2025 | IV Other |
| Pfizer INC. | $11.81 | 2019 | |
| Terumo Medical Corporation | $11.39 | 2019 | |
| Lemaitre Vascular, INC. | $11.18 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.99 | 2020 | |
| Polarityte, INC. | $10.07 | 2019 | |
| Elutia, INC. | $9.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Madsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.